Blood Test Shows Promise for Detecting Precancerous Ovarian Lesions
Researchers identified an RNA biomarker that detected precancerous fallopian tube lesions with 92.3% sensitivity and 98.2% specificity in a validation cohort.
Latest Articles
Editor's Top Picks
UW Medicine Implements Roche’s Automated Mass Spectrometry Platform for Patient Testing
The system began patient testing Nov 2, initially focusing on vitamin and hormone assays, with plans to expand into therapeutic drug monitoring and toxicology.
Be the First to Know What’s Next in the Lab
Every week, we dig into the biggest shifts, breakthroughs, and tech transforming clinical diagnostics. Straightforward, insightful, and always relevant.Critical Resources
Diagnostic Innovations
Labcorp Completes Millennium Health Acquisition to Expand Toxicology Testing
The deal adds a specialty laboratory focused on drug testing and surveillance to Labcorp's national network.
Equipment & Supply Spotlight
DNA/RNA Extraction Kit Designed to Simplify Molecular Testing Receives CE-IVD Mark
The kit allows laboratories to extract DNA and RNA from a range of clinical specimens using a single method.
News, Know-How & Standards
Disease Detection & Understanding
New Sequencing Panel Aims to Bring Leukemia Monitoring Into More Labs
The research-use-only assay combines two key genetic markers for acute myeloid leukemia in a single test, potentially reducing the need for separate testing workflows and reference lab send-outs.
